Literature DB >> 20707598

Facing up to toxic epidermal necrolysis.

Gérald E Piérard1, Philippe Paquet.   

Abstract

Toxic epidermal necrolysis (TEN) is a rare but life-threatening mucocutaneous adverse drug reaction. The disease is characterized by a specific and extensive destruction of the epidermis and mucosal epithelia, particularly of the mouth, genitalia and eyes. The TEN pathomechanism is probably initiated by a toxic drug metabolism inside keratinocytes, leading to a self-activation of apoptosis and necrosis. These events are boosted by additional effects of T lymphocytes and macrophages. At present there is still a lack of validated mainstay treatment for TEN. However, a few treatment modalities have been reported to halt TEN progression in some patients.

Entities:  

Mesh:

Year:  2010        PMID: 20707598     DOI: 10.1517/14656566.2010.512915

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  3 in total

1.  Revisiting cutaneous adverse reactions to pemetrexed.

Authors:  Claudine Piérard-Franchimont; Pascale Quatresooz; Marie-Annick Reginster; Gérald E Piérard
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

Review 2.  Idiosyncratic adverse drug reactions: current concepts.

Authors:  Jack Uetrecht; Dean J Naisbitt
Journal:  Pharmacol Rev       Date:  2013-03-08       Impact factor: 25.468

3.  Toxic Epidermal Necrolysis and Graft-versus-Host Reaction: Revisiting a Puzzling Similarity.

Authors:  G E Piérard; T Hermanns-Lê; P Paquet; A F Rousseau; P Delvenne; C Piérard-Franchimont
Journal:  ISRN Dermatol       Date:  2013-06-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.